ClinicalTrials.Veeva

Menu

Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke (AVC-NUT2)

U

University Hospital, Angers

Status

Enrolling

Conditions

Acute Stroke

Treatments

Dietary Supplement: Early nutritional management

Study type

Interventional

Funder types

Other

Identifiers

NCT07065929
49RC23_0302
2025-A00234-45 (Other Identifier)

Details and patient eligibility

About

This study evaluate the impact of early personalized nutritional management on 1-month mortality after acute stroke.

In the randomised centres of the interventional group (early personalized nutritional management), each patient will be assessed by a dietician within 2 days of stroke. Any swallowing problems are screened, and any barriers to eating are identified before dietary support. Patient's food intakes are recorded until the 7th day post-acute to assess their energy intake. Depending on patient's nutritional objectives, a reinforced feeding strategy comprising 2 levels is put in place, in order to prevent malnutrition: in level 1, the dietician tries to meet nutritional requirements orally, while in level 2 he can recourse to artificial nutrition in the event of failure or inability to meet requirements with oral intake alone. This strategy is started immediately after the initial assessment. Intakes are reassessed every 24 to 48 hours by the dietician in order to adapt the nutritional strategy as quickly as possible in order to cover the patient's personnalized nutritional needs.

No change in practice was required of the randomised centres in the control group.

All patients will be contacted by telephone 30 days after stroke to collect parts of the assessment criteria, while the other criteria will be collected directly from the patient's computerised medical record.

Three months after stroke, an evaluation of quality of life and modified Rankin test will be performed.

Our hypothesis is that the implementation of an individualized management of early nutritional support, aimed at compensating for the decrease in intake associated with the disease, would reduce mortality at 30 days in patients hospitalised for stroke.

Enrollment

3,084 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria :

  • Patients ≥ 18 years of age
  • With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke
  • NIHSS score ≥ 5
  • Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients
  • Stroke less than 2 days old
  • Anticipated length of hospital stay in a participating centre ≥ 5 days
  • Patient affiliated to or benefiting from a social security scheme
  • Patient or close relative having given written consent to participate in the study or patient included under the emergency procedure in the absence of contactable relatives

Exclusion Criteria:

  • Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as short bowel, extensive intestinal resections, etc.).
  • In a palliative situation where life expectancy is < 3 months
  • Patient taking part in another study with an impact on mortality or nutrition
  • Previous inclusion in the trial
  • Pregnant, breast-feeding or parturient woman
  • Patient unable to follow the protocol for any reason
  • Patient deprived of liberty by judicial or administrative decision
  • Patient under compulsory psychiatric care
  • Person under legal protection
  • Poor understanding of the French language

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3,084 participants in 2 patient groups

Interventional Group
Experimental group
Description:
early nutritional management
Treatment:
Dietary Supplement: Early nutritional management
Control Group
No Intervention group

Trial contacts and locations

12

Loading...

Central trial contact

Angélique CAMPION; Anthéa LOIEZ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems